Levonorgestrel
| Clinical data | |
|---|---|
| Trade names | Plan B, Plan B One-Step, others |
| Other names | LNG; LNG-EC; d-Norgestrel; d(–)-Norgestrel; D-Norgestrel; WY-5104; SH-90999; NSC-744007; 18-Methylnorethisterone; 17α-Ethynyl-18-methyl-19-nortestosterone; 17α-Ethynyl-18-methylestr-4-en-17β-ol-3-one; 13β-Ethyl-17α-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a610021 |
| Pregnancy category | |
| Routes of administration | By mouth, transdermal patch, intrauterine device, subcutaneous implant |
| Drug class | Progestogen (medication); Progestin |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 95% (range 85–100%)[8][9] |
| Protein binding | 98% (50% to albumin, 48% to SHBG)[8] |
| Metabolism | Liver (reduction, hydroxylation, conjugation)[8][10] |
| Metabolites | • 5α-Dihydro-LNG[8] |
| Elimination half-life | 24–32 hours[8] |
| Excretion | Urine: 20–67% Feces: 21–34%[10] |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.011.227 |
| Chemical and physical data | |
| Formula | C21H28O2 |
| Molar mass | 312.453 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 235 to 237 °C (455 to 459 °F) |
SMILES
| |
InChI
| |
| (verify) | |
Levonorgestrel is a hormonal medication used in a number of birth control methods.[7][11] It is combined with an estrogen to make combination birth control pills.[12] As an emergency birth control, sold under the brand names Plan B One-Step and Julie, among others, it is useful within 72 hours of unprotected sex.[7][11][13] The more time that has passed since sex, the less effective the medication becomes.[11] Levonorgestrel works by preventing or delaying ovulation so an egg cannot be released. The dosage used for emergency contraception is ineffective when ovulation has already occurred, and has been found to have no effect on implantation.[14] It decreases the chances of pregnancy by 57–93%.[15] In an intrauterine device (IUD), such as Mirena among others, it is effective for the long-term prevention of pregnancy.[11] A levonorgestrel-releasing implant is also available in some countries.[16]
Common side effects include nausea, breast tenderness, headaches, and increased, decreased, or irregular menstrual bleeding.[11] When used as an emergency contraceptive, if pregnancy occurs, there is no evidence that its use harms the fetus.[11] It is safe to use during breastfeeding.[11] Birth control that contains levonorgestrel will not change the risk of sexually transmitted infections.[11] It is a progestin and has effects similar to those of the hormone progesterone.[11] It works primarily by preventing ovulation and closing off the cervix to prevent the passage of sperm.[11]
Levonorgestrel was patented in 1960 and introduced for medical use together with ethinylestradiol in 1970.[17][18] It is on the World Health Organization's List of Essential Medicines.[19] It is available as a generic medication.[20] In the United States, levonorgestrel-containing emergency contraceptives are available over the counter (OTC) for all ages.[21] In 2020, it was the 323rd most commonly prescribed medication in the United States, with more than 800 thousand prescriptions.[22]
- ^ a b "Levonorgestrel Use During Pregnancy". Drugs.com. 23 March 2020. Archived from the original on 2 July 2020. Retrieved 29 June 2020.
- ^ "Norplant Product information". Health Canada. 24 September 2002. Retrieved 17 February 2025.
- ^ "Plan B Product information". Health Canada. 9 May 2018. Retrieved 17 February 2025.
- ^ "Backup Plan Product information". Health Canada. 4 May 2019. Retrieved 17 February 2025.
- ^ "Backup Plan Onestep Product information". Health Canada. 7 June 2016. Retrieved 17 February 2025.
- ^ "Jaydess 13.5 mg intrauterine delivery system - Summary of Product Characteristics (SmPC)". (emc). 1 July 2022. Archived from the original on 13 April 2021. Retrieved 1 July 2022.
- ^ a b c "Plan B One-Step- levonorgestrel tablet". DailyMed. 21 December 2022. Retrieved 26 December 2022.
- ^ a b c d e Cite error: The named reference
pmid16112947was invoked but never defined (see the help page). - ^ Cite error: The named reference
pmid8842581was invoked but never defined (see the help page). - ^ a b Cite error: The named reference
ShoupeHaseltine2012was invoked but never defined (see the help page). - ^ a b c d e f g h i j "Progestins (Etonogestrel, Levonorgestrel, Norethindrone)". The American Society of Health-System Pharmacists. Archived from the original on 7 September 2015. Retrieved 21 August 2015.
- ^ Postgraduate Gynecology. Jaypee Brothers Medical Pub. 2011. p. 159. ISBN 9789350250822. Archived from the original on 26 September 2015.
- ^ "Levonorgestrel 1.5 mg Tablet Emergency Contraceptive: New Drug Application 21998, Supplement 5" (PDF). U.S. Food and Drug Administration. Archived from the original (PDF) on 23 December 2022.
- ^ "Plan B One-Step (1.5 mg levonorgestrel) Information". FDA. 2022. Archived from the original on 23 December 2022.
- ^ Gemzell-Danielsson K (November 2010). "Mechanism of action of emergency contraception". Contraception. 82 (5): 404–409. doi:10.1016/j.contraception.2010.05.004. PMID 20933113.
- ^ "Chapter 1". Research on reproductive health at WHO: biennial report 2000-2001. Geneva: World health organization. 2002. ISBN 9789241562089. Archived from the original on 26 September 2015.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 479. ISBN 9783527607495. Archived from the original on 28 August 2021. Retrieved 5 August 2020.
- ^ Cite error: The named reference
Roth2014was invoked but never defined (see the help page). - ^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ^ Hamilton RJ (2014). Tarascon pocket pharmacopoeia : 2014 deluxe lab-pocket edition (15th ed.). Sudbury: Jones & Bartlett Learning. pp. 310–312. ISBN 9781284053999. Archived from the original on 26 September 2015.
- ^ "FDA approves Plan B One-Step emergency contraceptive for use without a prescription for all women of child-bearing potential" (Press release). 20 June 2013. Archived from the original on 14 January 2016. Retrieved 2 February 2016.
- ^ "Levonorgestrel - Drug Usage Statistics". ClinCalc. Retrieved 7 October 2022.